VRAY - ビュ―レイ (ViewRay Inc.)

VRAYのニュース

   Jefferies downgrades ViewRay Inc to Hold  2023/04/17 07:36:37 Investing.com
https://www.investing.com/news/pro/viewray-inc-receives-investment-bank-analyst-rating-update-3056562
   ViewRay extends losses as Street downgrades after guidance cut  2023/04/14 12:26:06 Seeking Alpha
ViewRay (VRAY) shares extended losses Friday as three analysts downgraded the stock after the MedTech company slashed its 2023 outlook. Read more here.
   Stifel downgrades ViewRay Inc to Hold  2023/04/14 07:17:37 Investing.com
https://www.investing.com/news/pro/viewray-inc-receives-investment-bank-analyst-rating-update-3055452
   ViewRay: Shares Crater As Company Warns Of Slower Growth, Higher Cash Burn  2023/04/13 23:28:13 Seeking Alpha
ViewRay, Inc. has shocked investors with a severe revenue and cash flow warning. VRAY now expects much lower 2023 revenue growth. Click here for our take on VRAY.
   Why ViewRay Shares Are Trading Lower By 32%? Here Are Other Stocks Moving In Thursday''s Mid-Day Session  2023/04/13 16:24:13 Benzinga
Gainers CXApp Inc. (NASDAQ: CXAI ) jumped 105% to $3.28 after climbing over 20% on Wednesday. SAB Biotherapeutics, Inc. (NASDAQ: SABS ) gained 71% to $0.6587 after the company said it has been granted Fast Track designation from the FDA for SAB-176 influenza immunotherapy with high cross-reactivity to multiple strains of influenza. Auddia Inc. (NASDAQ: AUUD ) jumped 68.2% to $0.8917 after gaining more than 10% on Wednesday. Ocean Biomedical, Inc. (NASDAQ: OCEA ) jumped 50% to $6.76. Ocean Biomedical’s co-founder, Jonathan Kurtis, has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for his U.S. patent application covering a therapeutic and prophylactic monoclonal antibody that kills falciparum malaria parasites. Consolidated Communications Holdings, Inc. (NASDAQ: CNSL ) shares jumped 35.5% to $3.74 after Searchlight Capital and BCI submitted a non-binding proposal to acquire all outstanding shares of Consolidated Communications not owned by Searchlight or BCI for $4 per share.
   Military University Hospital Prague Selects ViewRay''s MRIdian® MRI-Guided Radiation Therapy System to Treat Cancer Patients  2023/03/07 11:30:00 Benzinga
First and only MRIdian in the Czech Republic to bring advanced MRI-guided radiation therapy to the region DENVER , March 7, 2023 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY ) today announced the Czech Ministry of Health has approved the purchase of ViewRay''s MRIdian system to bring advanced MRI-guided radiation therapy to treat its cancer patients at the Military University Hospital Prague in the Czech Republic . This is the first and only hospital to offer the precision of MRIdian Stereotactic MRI-guided Adaptive Radiotherapy (SMART) in the Czech Republic . The purchase was co-financed by the REACT-EU financial instrument and the founder''s contribution, the Ministry of Defense of the Czech Republic . The Military University Hospital Prague is a training, educational, and professional medical facility of the Army of the Czech Republic . It provides comprehensive health care at the level of teaching hospitals to members of the Czech Army, war veterans, and people in and outside the region.
   Military University Hospital Prague Selects ViewRay''s MRIdian MRI-Guided Radiation Therapy System to Treat Cancer Patients  2023/03/07 11:30:00 PR Newswire
First and only MRIdian in the Czech Republic to bring advanced MRI-guided radiation therapy to the region DENVER, March 7, 2023 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced the Czech Ministry of Health has approved the purchase of ViewRay''s MRIdian system to bring advanced…
   ViewRay Earnings Perspective: Return On Capital Employed  2023/03/02 14:49:45 Benzinga
Benzinga Pro data, ViewRay (NASDAQ: VRAY ) reported Q4 sales of $34.69 million. Earnings fell to a loss of $27.82 million, resulting in a 6.55% decrease from last quarter. In Q3, ViewRay brought in $26.49 million in sales but lost $26.11 million in earnings. What Is Return On Capital Employed? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative of successful growth of a company and is … Full story available on Benzinga.com
   ViewRay, Inc. 2023 Q4 - Results - Earnings Call Presentation (NASDAQ:VRAY)  2023/03/01 17:39:51 Seeking Alpha
The following slide deck was published by ViewRay, Inc.
   ViewRay, Inc. (VRAY) Q4 2022 Earnings Call Transcript  2023/02/28 01:42:05 Seeking Alpha
ViewRay, Inc. (NASDAQ:NASDAQ:VRAY) Q4 2022 Earnings Conference Call February 27, 2023 4:30 PM ETCompany ParticipantsMatt Harrison - Director of IRScott Drake - President and CEO Bill Burke…
   Military University Hospital Prague Selects ViewRay''s MRIdian® MRI-Guided Radiation Therapy System to Treat Cancer Patients  2023/03/07 11:30:00 Benzinga
First and only MRIdian in the Czech Republic to bring advanced MRI-guided radiation therapy to the region DENVER , March 7, 2023 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY ) today announced the Czech Ministry of Health has approved the purchase of ViewRay''s MRIdian system to bring advanced MRI-guided radiation therapy to treat its cancer patients at the Military University Hospital Prague in the Czech Republic . This is the first and only hospital to offer the precision of MRIdian Stereotactic MRI-guided Adaptive Radiotherapy (SMART) in the Czech Republic . The purchase was co-financed by the REACT-EU financial instrument and the founder''s contribution, the Ministry of Defense of the Czech Republic . The Military University Hospital Prague is a training, educational, and professional medical facility of the Army of the Czech Republic . It provides comprehensive health care at the level of teaching hospitals to members of the Czech Army, war veterans, and people in and outside the region.
   Military University Hospital Prague Selects ViewRay''s MRIdian MRI-Guided Radiation Therapy System to Treat Cancer Patients  2023/03/07 11:30:00 PR Newswire
First and only MRIdian in the Czech Republic to bring advanced MRI-guided radiation therapy to the region DENVER, March 7, 2023 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced the Czech Ministry of Health has approved the purchase of ViewRay''s MRIdian system to bring advanced…
   ViewRay Earnings Perspective: Return On Capital Employed  2023/03/02 14:49:45 Benzinga
Benzinga Pro data, ViewRay (NASDAQ: VRAY ) reported Q4 sales of $34.69 million. Earnings fell to a loss of $27.82 million, resulting in a 6.55% decrease from last quarter. In Q3, ViewRay brought in $26.49 million in sales but lost $26.11 million in earnings. What Is Return On Capital Employed? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative of successful growth of a company and is … Full story available on Benzinga.com
   ViewRay, Inc. 2023 Q4 - Results - Earnings Call Presentation (NASDAQ:VRAY)  2023/03/01 17:39:51 Seeking Alpha
The following slide deck was published by ViewRay, Inc.
   ViewRay, Inc. (VRAY) Q4 2022 Earnings Call Transcript  2023/02/28 01:42:05 Seeking Alpha
ViewRay, Inc. (NASDAQ:NASDAQ:VRAY) Q4 2022 Earnings Conference Call February 27, 2023 4:30 PM ETCompany ParticipantsMatt Harrison - Director of IRScott Drake - President and CEO Bill Burke…

calendar